Tuesday, December 12, 2017 12:10:00 AM
You've done a good job here but it is time to accept the company as viable finally. The puttable warrants for cash would be a drag on a potential takeover given the terms (puttable upon a fundamental transaction, spelled out more clearly on the S1/A filed in Aug 2016) but I'm not investing in this on a chance takeover.
Their skies are finally clearing after brutal years of funding starvation in their niche markets. Some competition never made it thru. The Applied Optics purchase was also very well timed looking back now (wouldn't have said that a year ago).
They will start showing good cashflow moving forward in my opinion (debt paid down, low CapEx generally, ARs good collectibility, lowish inventory levels). Still need to see where earnings and backlog come in once the annual report comes out this month.
They are showing signs of life both on the govt military side and the commercial/retail side. That should become more evident soon IMO. Wish I could have built a bigger position around $0.9 area ahead of the annual but a little buying came in last few days.
Good luck, all IMO only.
I don't mind stealing bread from the mouths of decadence... But I can't feed on the powerless when my cup's already overfilled.
-Temple of the Dog
Recent OPXS News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 08:46:32 PM
- LifeVantage Appoints Dayton Judd to the Board of Directors • GlobeNewswire Inc. • 02/15/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 02:30:11 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/22/2024 09:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 09:30:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 09:22:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 11:04:26 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM